ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2023

The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.

Marjan Gharagozloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.